NCT01118832 Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi Status COMPLETED Phase N/A
NCT01118091 Prospective Randomized Comparative Study of Cell Transfer Therapy Using CD8+-Enriched Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Compared to High-Dose Aldesleukin in M... Status COMPLETED Phase PHASE2
NCT01106040 Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes Status COMPLETED Phase PHASE3
NCT01092728 Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma Status TERMINATED Phase PHASE2
NCT01092585 Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH Status UNKNOWN Phase PHASE2
NCT01085396 Use of Fiber-optic Probe for Non-invasive Diagnosis of Melanoma and Assessment of Impact of Ultraviolet (UV) Exposure on Skin Status TERMINATED Phase N/A
NCT01079741 Safety Study of Adjuvant Vaccine to Treat Melanoma Patients Status COMPLETED Phase PHASE1/PHASE2
NCT01078961 An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma Status COMPLETED Phase PHASE1
NCT01068470 Determining the Lymphokine Activated Killer (LAK) Cytotoxicity Present in Patients Undergoing Interleukin-2 Therapy Status TERMINATED Phase N/A
NCT01067066 A Phase I Study of TPI 287 - Temozolomide Combination in Melanoma Status TERMINATED Phase PHASE1
NCT01066390 A Study on the Safety and Immunogenicity of Combined Intradermal and Intravenous Administration of an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Previously Treated Unresectable Stage III or IV Melanoma Status COMPLETED Phase PHASE1
NCT01065441 Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01052142 Safety Study of a Liposomal Vaccine to Treat Malignant Melanoma Status COMPLETED Phase PHASE1
NCT01048554 Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System Status COMPLETED Phase PHASE2
NCT01045915 Safety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic Melanoma Status TERMINATED Phase PHASE1
NCT01034696 Pain Prevalence and Risk Factors Among Sarcoma/Melanoma Oncology Patients in an Outpatients Setting Status COMPLETED Phase N/A
NCT01028222 A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation Status COMPLETED Phase PHASE2